Obalon Therapeutics, Inc. (OBLN) Stock Analysis
DELISTED
What happened to Obalon Therapeutics, Inc. (OBLN) stock?
Obalon Therapeutics, Inc. (OBLN) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
P/E 9.53 means the share price is 9.53 times one year of earnings per share. Market cap $5.47M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Obalon Therapeutics, Inc. (OBLN). Obalon Therapeutics, Inc. is a medical device company focused on innovative weight reduction solutions for obese patients.
Last analyzed: Jun 14, 2026Obalon Therapeutics, Inc. (OBLN) Healthcare & Pipeline Overview
More about this archive record
Can I still buy OBLN shares?
No. OBLN stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for OBLN elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before OBLN stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Obalon Therapeutics, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.